Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Notes: Requires reconstitution with bacteriostatic water
While AOD 9604 offers a safer and potentially cost-effective approach with added joint health benefits, Semaglutide stands out as the most effective option for significant weight loss, supported by robust clinical research
Summary: Retatrutide and 5-Amino-1MQ are both unlicensed compounds in the UK retatrutide is an investigational triple incretin receptor agonist in clinical trials, whilst 5-Amino-1MQ is a research chemical with no approved human therapeutic use
The 50 mg vials larger, cleaner draw is easier to measure
Our team will help you build the right plan based on your goals
US$ 20.35
:max_bytes(150000):strip_icc()/health-GettyImages-1498826563-72ccaac18ecf41e49988eccfc823270f.jpg)
US$ 27.81
US$ 24.92
US$ 26.41
